(Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 93.99%-140.36K | -130.71%-23.78M | -4,447.27%-22.09M | 56.54%-445.7K | 111.14%1.09M | -1,272.39%-2.34M | -119.76%-10.31M | 298.23%508.03K | -551.79%-1.03M | -10,441.15%-9.79M |
Net income from continuing operations | -96.06%56.04K | -1,637.35%-41.93M | -5,000.49%-36.89M | -565.39%-2.37M | -207.30%-4.1M | -36.62%1.42M | 97.66%-2.41M | 99.11%-723.18K | 93.01%-356.1K | 80.55%-1.33M |
Operating gains losses | 77.73%-934.66K | 73.56%-4.92M | -0.35%-6.34M | -108.83%-131.99K | 150.51%5.75M | 66.66%-4.2M | -468.40%-18.6M | -215.61%-6.32M | 353.39%1.49M | -5,673.63%-11.39M |
Depreciation and amortization | --0 | -60.53%145.52K | -83.38%26.2K | -32.68%27.36K | -84.45%26.49K | -41.17%65.47K | -63.83%368.72K | -64.98%157.7K | -75.45%40.65K | -34.54%170.38K |
Asset impairment expenditure | --0 | 314.57%2.36M | 94.38%1.07M | --1.29M | -907.78%-154.93K | 1,114.98%157.12K | -99.22%569.28K | -99.25%550.1K | --0 | --19.18K |
Remuneration paid in stock | ---- | --18.09M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | 125.12%50K | 431.72%648.02K | 112.86%25.12K | --55.15K | --545.55K | --22.21K | 95.71%-195.35K | ---195.35K | --0 | --0 |
Remuneration paid in stock | --0 | --88.85K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other non cashItems | 3.72%604.84K | -79.09%2.49M | -69.76%2.04M | 180.34%824.5K | -125.09%-955.89K | -89.19%583.18K | -16.86%11.91M | 22.87%6.74M | 59.12%-1.03M | 8.35%3.81M |
Change In working capital | 121.41%83.42K | 61.71%-748.02K | -167.51%-197.15K | 88.13%-139.85K | 98.00%-21.31K | -108.37%-389.72K | -132.62%-1.95M | 108.02%292.04K | -114.22%-1.18M | -159.09%-1.07M |
-Change in receivables | 103.54%2.32K | 76.58%-464.25K | 65.64%-397.26K | 99.07%-7.42K | 124.96%6K | -490.16%-65.57K | -252.60%-1.98M | -12.32%-1.16M | -196.17%-801.62K | -3.20%-24.02K |
-Change in inventory | -631.09%-56.23K | -75.51%2.99K | -487.07%-53.71K | -102.39%-789 | 502.54%46.89K | 142.21%10.59K | -38.01%12.19K | -105.10%-9.15K | 553.21%32.99K | 43.95%-11.65K |
-Change in prepaid assets | 59.86%16.21K | -30.66%-31.22K | 218.10%20.42K | -396.56%-66.6K | -29.19%4.83K | 202.66%10.14K | -104.58%-23.89K | -126.67%-17.29K | -139.51%-13.41K | -98.11%6.81K |
-Change in payables and accrued expense | 135.12%121.12K | -735.67%-255.54K | -84.17%233.4K | 83.57%-65.04K | 92.39%-79.02K | -107.34%-344.88K | -99.33%40.2K | 151.61%1.47M | -105.34%-395.97K | -169.70%-1.04M |
Cash from discontinued investing activities | -101.74%-27.52K | 1.58M | ||||||||
Operating cash flow | 77.71%-167.88K | -130.71%-23.78M | -4,447.27%-22.09M | 56.54%-445.7K | 94.96%-493.3K | -342.20%-753.09K | -119.76%-10.31M | 298.23%508.03K | -551.79%-1.03M | -10,441.15%-9.79M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 107.17%91.21K | -116.11%-1.26M | 100.14%8.31K | 0 | 0 | -2,370.40%-1.27M | 168.61%7.84M | -1,595.04%-6.01M | 213.11%883.73K | 487.41%12.97M |
Capital expenditure reported | ---- | --0 | ---- | ---- | ---- | ---- | 99.85%-8.39K | ---- | ---- | ---- |
Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---361 | --5.17M |
Net intangibles purchas and sale | ---- | --0 | --0 | --0 | ---- | ---- | -3.65%-23K | 203.65%23K | --0 | ---46K |
Net business purchase and sale | --0 | ---- | ---- | --0 | --0 | ---1.27M | ---- | ---- | ---- | --0 |
Net investment purchase and sale | --91.21K | -116.05%-1.26M | -48.65%-1.26M | --0 | --0 | --0 | --7.87M | -116.98%-850K | --881.22K | 1,360.69%7.84M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 107.17%91.21K | -116.11%-1.26M | 100.14%8.31K | --0 | --0 | -2,370.40%-1.27M | 168.61%7.84M | -1,595.04%-6.01M | 213.11%883.73K | 487.41%12.97M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -66.32%382.67K | 401.58%382.67K | 0 | -90.78%1.14M | -72.27%76.29K | -85.69%121.08K | -68.43%938.96K | |||
Net issuance payments of debt | ---- | --0 | --0 | --0 | ---- | ---- | -98.71%127.34K | -76.20%65.47K | 384.30%71.08K | -100.65%-9.21K |
Net other financing activities | ---- | -62.07%382.67K | ---- | ---- | ---- | ---- | --1.01M | --10.83K | --50K | --948.17K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | -66.32%382.67K | 401.58%382.67K | --0 | ---- | ---- | -90.78%1.14M | -72.27%76.29K | -85.69%121.08K | -68.43%938.96K |
Net cash flow | ||||||||||
Beginning cash position | -90.16%304.26K | 1,027.36%3.09M | -95.61%191.75K | -85.61%631.15K | 297.00%1.09M | 1,027.36%3.09M | -93.27%274.39K | 1,828.83%4.37M | 1,274.78%4.39M | -54.12%274.39K |
Current changes in cash | 96.21%-76.67K | -199.78%-2.75M | 115.67%209.8K | -2,045.46%-445.7K | -111.97%-493.3K | -180.91%-2.02M | 172.60%2.76M | -2,884.56%-1.34M | 77.59%-20.77K | 1,576.35%4.12M |
Effect of exchange rate changes | -317.20%-45.33K | -159.40%-35.01K | -244.94%-97.29K | --6.3K | 528.88%35.11K | 354.93%20.87K | --58.94K | --67.13K | --0 | ---8.19K |
End cash Position | -83.27%182.25K | -90.16%304.26K | -90.16%304.26K | -95.61%191.75K | -85.61%631.15K | -60.66%1.09M | 1,027.36%3.09M | 1,027.36%3.09M | 1,828.83%4.37M | 1,274.78%4.39M |
Free cash from | 77.71%-167.88K | -130.01%-23.78M | -4,325.77%-22.09M | 56.54%-445.7K | 94.98%-493.3K | -239.55%-753.09K | -0.08%-10.34M | -42.56%522.63K | -9.26%-1.03M | -229.92%-9.83M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.